PATENT CLAIM ANALYSIS

Application Number: 15877598
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "191100"]

Abstract:
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine vectors include a polynucleotide encoding a Rhomboid polypeptide and optionally include an immune-stimulatory polypeptide suitably expressed on the surface of the vaccine vector.

Claim (Index 17):
The method of  claim 16 , wherein the enhanced immune response comprises an enhanced antibody response, an enhanced T cell response or both.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.41463
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14768011', '12740608', '14623050', '14776986', '13574504']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7782990965515405
- 35 USC 102 Novelty (BERT): 0.5711503008825348
- Combined Prediction Score: 0.75758421698464
- Mean Citation Score: 355.638482
- Max Citation Score: 459.58566
- Similarity Product: 387.5465284337319

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test